Skip to main content
. 2022 Dec 28;4(1):101975. doi: 10.1016/j.xpro.2022.101975

Figure 5.

Figure 5

In utero ICV injection achieves long-term targeting of postnatal ChP and CSF

Lysates of ChP (left panels) or CSF (right panels) transduced with either AAV-hSOD3 or control (AAV-GFP) were probed with hSOD3 or Vinculin antibodies at (A) E18.5, (B) 2 weeks, (C) 6 weeks, and (D) 10 weeks.